Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Subcutaneous immunotherapy (SCIT) is a unique therapy for allergic disease because it provides symptomatic relief while modifying the allergic disease by targeting the underlying immunological mechanism.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Subcutaneous Immunotherapy market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Subcutaneous Immunotherapy market. Detailed analysis of key players, along with key growth strategies adopted by Subcutaneous Immunotherapy industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Circassia
Allergy Therapeutics
Aimmune Therapeutics
Merck KGaA
Anergis
HAL Allergy BV
Biomay AG
Stallergenes Greer
DBV Technologies
ALK
By Type:
Asthma
Allergic Rhinitis
Venom Allergy
Food Allergy
By End-User:
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Subcutaneous Immunotherapy Market
-
1.3 Market Segment by Type
-
1.3.1 China Subcutaneous Immunotherapy Market Size and Growth Rate of Asthma from 2016 to 2027
-
1.3.2 China Subcutaneous Immunotherapy Market Size and Growth Rate of Allergic Rhinitis from 2016 to 2027
-
1.3.3 China Subcutaneous Immunotherapy Market Size and Growth Rate of Venom Allergy from 2016 to 2027
-
1.3.4 China Subcutaneous Immunotherapy Market Size and Growth Rate of Food Allergy from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Subcutaneous Immunotherapy Market Size and Growth Rate of Hospital Pharmacies from 2016 to 2027
-
1.4.2 China Subcutaneous Immunotherapy Market Size and Growth Rate of Online Pharmacies from 2016 to 2027
-
1.4.3 China Subcutaneous Immunotherapy Market Size and Growth Rate of Retail Pharmacies from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Subcutaneous Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Subcutaneous Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Subcutaneous Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Subcutaneous Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Subcutaneous Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Subcutaneous Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Subcutaneous Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Subcutaneous Immunotherapy Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Subcutaneous Immunotherapy by Major Types
-
3.4.1 Market Size and Growth Rate of Asthma
-
3.4.2 Market Size and Growth Rate of Allergic Rhinitis
-
3.4.3 Market Size and Growth Rate of Venom Allergy
-
3.4.4 Market Size and Growth Rate of Food Allergy
4 Segmentation of Subcutaneous Immunotherapy Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Subcutaneous Immunotherapy by Major End-Users
-
4.4.1 Market Size and Growth Rate of Subcutaneous Immunotherapy in Hospital Pharmacies
-
4.4.2 Market Size and Growth Rate of Subcutaneous Immunotherapy in Online Pharmacies
-
4.4.3 Market Size and Growth Rate of Subcutaneous Immunotherapy in Retail Pharmacies
5 Market Analysis by Regions
-
5.1 China Subcutaneous Immunotherapy Production Analysis by Regions
-
5.2 China Subcutaneous Immunotherapy Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Subcutaneous Immunotherapy Landscape Analysis
-
6.1 North China Subcutaneous Immunotherapy Landscape Analysis by Major Types
-
6.2 North China Subcutaneous Immunotherapy Landscape Analysis by Major End-Users
7 Central China Subcutaneous Immunotherapy Landscape Analysis
-
7.1 Central China Subcutaneous Immunotherapy Landscape Analysis by Major Types
-
7.2 Central China Subcutaneous Immunotherapy Landscape Analysis by Major End-Users
8 South China Subcutaneous Immunotherapy Landscape Analysis
-
8.1 South China Subcutaneous Immunotherapy Landscape Analysis by Major Types
-
8.2 South China Subcutaneous Immunotherapy Landscape Analysis by Major End-Users
9 East China Subcutaneous Immunotherapy Landscape Analysis
-
9.1 East China Subcutaneous Immunotherapy Landscape Analysis by Major Types
-
9.2 East China Subcutaneous Immunotherapy Landscape Analysis by Major End-Users
10 Northeast China Subcutaneous Immunotherapy Landscape Analysis
-
10.1 Northeast China Subcutaneous Immunotherapy Landscape Analysis by Major Types
-
10.2 Northeast China Subcutaneous Immunotherapy Landscape Analysis by Major End-Users
11 Southwest China Subcutaneous Immunotherapy Landscape Analysis
-
11.1 Southwest China Subcutaneous Immunotherapy Landscape Analysis by Major Types
-
11.2 Southwest China Subcutaneous Immunotherapy Landscape Analysis by Major End-Users
12 Northwest China Subcutaneous Immunotherapy Landscape Analysis
-
12.1 Northwest China Subcutaneous Immunotherapy Landscape Analysis by Major Types
-
12.2 Northwest China Subcutaneous Immunotherapy Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Circassia
-
13.1.1 Circassia Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Allergy Therapeutics
-
13.2.1 Allergy Therapeutics Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Aimmune Therapeutics
-
13.3.1 Aimmune Therapeutics Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Merck KGaA
-
13.4.1 Merck KGaA Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Anergis
-
13.5.1 Anergis Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 HAL Allergy BV
-
13.6.1 HAL Allergy BV Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Biomay AG
-
13.7.1 Biomay AG Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Stallergenes Greer
-
13.8.1 Stallergenes Greer Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 DBV Technologies
-
13.9.1 DBV Technologies Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
-
13.10 ALK
-
13.10.1 ALK Company Profile and Recent Development
-
13.10.2 Market Performance
-
13.10.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Subcutaneous Immunotherapy Market Size and Growth Rate of Asthma from 2016 to 2027
-
Figure China Subcutaneous Immunotherapy Market Size and Growth Rate of Allergic Rhinitis from 2016 to 2027
-
Figure China Subcutaneous Immunotherapy Market Size and Growth Rate of Venom Allergy from 2016 to 2027
-
Figure China Subcutaneous Immunotherapy Market Size and Growth Rate of Food Allergy from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Subcutaneous Immunotherapy Market Size and Growth Rate of Hospital Pharmacies from 2016 to 2027
-
Figure China Subcutaneous Immunotherapy Market Size and Growth Rate of Online Pharmacies from 2016 to 2027
-
Figure China Subcutaneous Immunotherapy Market Size and Growth Rate of Retail Pharmacies from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Subcutaneous Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Subcutaneous Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Subcutaneous Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Subcutaneous Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Subcutaneous Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Subcutaneous Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Subcutaneous Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Subcutaneous Immunotherapy Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Subcutaneous Immunotherapy
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Subcutaneous Immunotherapy by Different Types from 2016 to 2027
-
Table Consumption Share of Subcutaneous Immunotherapy by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Asthma
-
Figure Market Size and Growth Rate of Allergic Rhinitis
-
Figure Market Size and Growth Rate of Venom Allergy
-
Figure Market Size and Growth Rate of Food Allergy
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Subcutaneous Immunotherapy by Different End-Users from 2016 to 2027
-
Table Consumption Share of Subcutaneous Immunotherapy by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospital Pharmacies
-
Figure Market Size and Growth Rate of Online Pharmacies
-
Figure Market Size and Growth Rate of Retail Pharmacies
-
Table China Subcutaneous Immunotherapy Production by Regions
-
Table China Subcutaneous Immunotherapy Production Share by Regions
-
Figure China Subcutaneous Immunotherapy Production Share by Regions in 2016
-
Figure China Subcutaneous Immunotherapy Production Share by Regions in 2021
-
Figure China Subcutaneous Immunotherapy Production Share by Regions in 2027
-
Table China Subcutaneous Immunotherapy Consumption by Regions
-
Table China Subcutaneous Immunotherapy Consumption Share by Regions
-
Figure China Subcutaneous Immunotherapy Consumption Share by Regions in 2016
-
Figure China Subcutaneous Immunotherapy Consumption Share by Regions in 2021
-
Figure China Subcutaneous Immunotherapy Consumption Share by Regions in 2027
-
Table North China Subcutaneous Immunotherapy Consumption by Types from 2016 to 2027
-
Table North China Subcutaneous Immunotherapy Consumption Share by Types from 2016 to 2027
-
Figure North China Subcutaneous Immunotherapy Consumption Share by Types in 2016
-
Figure North China Subcutaneous Immunotherapy Consumption Share by Types in 2021
-
Figure North China Subcutaneous Immunotherapy Consumption Share by Types in 2027
-
Table North China Subcutaneous Immunotherapy Consumption by End-Users from 2016 to 2027
-
Table North China Subcutaneous Immunotherapy Consumption Share by End-Users from 2016 to 2027
-
Figure North China Subcutaneous Immunotherapy Consumption Share by End-Users in 2016
-
Figure North China Subcutaneous Immunotherapy Consumption Share by End-Users in 2021
-
Figure North China Subcutaneous Immunotherapy Consumption Share by End-Users in 2027
-
Table Central China Subcutaneous Immunotherapy Consumption by Types from 2016 to 2027
-
Table Central China Subcutaneous Immunotherapy Consumption Share by Types from 2016 to 2027
-
Figure Central China Subcutaneous Immunotherapy Consumption Share by Types in 2016
-
Figure Central China Subcutaneous Immunotherapy Consumption Share by Types in 2021
-
Figure Central China Subcutaneous Immunotherapy Consumption Share by Types in 2027
-
Table Central China Subcutaneous Immunotherapy Consumption by End-Users from 2016 to 2027
-
Table Central China Subcutaneous Immunotherapy Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Subcutaneous Immunotherapy Consumption Share by End-Users in 2016
-
Figure Central China Subcutaneous Immunotherapy Consumption Share by End-Users in 2021
-
Figure Central China Subcutaneous Immunotherapy Consumption Share by End-Users in 2027
-
Table South China Subcutaneous Immunotherapy Consumption by Types from 2016 to 2027
-
Table South China Subcutaneous Immunotherapy Consumption Share by Types from 2016 to 2027
-
Figure South China Subcutaneous Immunotherapy Consumption Share by Types in 2016
-
Figure South China Subcutaneous Immunotherapy Consumption Share by Types in 2021
-
Figure South China Subcutaneous Immunotherapy Consumption Share by Types in 2027
-
Table South China Subcutaneous Immunotherapy Consumption by End-Users from 2016 to 2027
-
Table South China Subcutaneous Immunotherapy Consumption Share by End-Users from 2016 to 2027
-
Figure South China Subcutaneous Immunotherapy Consumption Share by End-Users in 2016
-
Figure South China Subcutaneous Immunotherapy Consumption Share by End-Users in 2021
-
Figure South China Subcutaneous Immunotherapy Consumption Share by End-Users in 2027
-
Table East China Subcutaneous Immunotherapy Consumption by Types from 2016 to 2027
-
Table East China Subcutaneous Immunotherapy Consumption Share by Types from 2016 to 2027
-
Figure East China Subcutaneous Immunotherapy Consumption Share by Types in 2016
-
Figure East China Subcutaneous Immunotherapy Consumption Share by Types in 2021
-
Figure East China Subcutaneous Immunotherapy Consumption Share by Types in 2027
-
Table East China Subcutaneous Immunotherapy Consumption by End-Users from 2016 to 2027
-
Table East China Subcutaneous Immunotherapy Consumption Share by End-Users from 2016 to 2027
-
Figure East China Subcutaneous Immunotherapy Consumption Share by End-Users in 2016
-
Figure East China Subcutaneous Immunotherapy Consumption Share by End-Users in 2021
-
Figure East China Subcutaneous Immunotherapy Consumption Share by End-Users in 2027
-
Table Northeast China Subcutaneous Immunotherapy Consumption by Types from 2016 to 2027
-
Table Northeast China Subcutaneous Immunotherapy Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Subcutaneous Immunotherapy Consumption Share by Types in 2016
-
Figure Northeast China Subcutaneous Immunotherapy Consumption Share by Types in 2021
-
Figure Northeast China Subcutaneous Immunotherapy Consumption Share by Types in 2027
-
Table Northeast China Subcutaneous Immunotherapy Consumption by End-Users from 2016 to 2027
-
Table Northeast China Subcutaneous Immunotherapy Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Subcutaneous Immunotherapy Consumption Share by End-Users in 2016
-
Figure Northeast China Subcutaneous Immunotherapy Consumption Share by End-Users in 2021
-
Figure Northeast China Subcutaneous Immunotherapy Consumption Share by End-Users in 2027
-
Table Southwest China Subcutaneous Immunotherapy Consumption by Types from 2016 to 2027
-
Table Southwest China Subcutaneous Immunotherapy Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Subcutaneous Immunotherapy Consumption Share by Types in 2016
-
Figure Southwest China Subcutaneous Immunotherapy Consumption Share by Types in 2021
-
Figure Southwest China Subcutaneous Immunotherapy Consumption Share by Types in 2027
-
Table Southwest China Subcutaneous Immunotherapy Consumption by End-Users from 2016 to 2027
-
Table Southwest China Subcutaneous Immunotherapy Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Subcutaneous Immunotherapy Consumption Share by End-Users in 2016
-
Figure Southwest China Subcutaneous Immunotherapy Consumption Share by End-Users in 2021
-
Figure Southwest China Subcutaneous Immunotherapy Consumption Share by End-Users in 2027
-
Table Northwest China Subcutaneous Immunotherapy Consumption by Types from 2016 to 2027
-
Table Northwest China Subcutaneous Immunotherapy Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Subcutaneous Immunotherapy Consumption Share by Types in 2016
-
Figure Northwest China Subcutaneous Immunotherapy Consumption Share by Types in 2021
-
Figure Northwest China Subcutaneous Immunotherapy Consumption Share by Types in 2027
-
Table Northwest China Subcutaneous Immunotherapy Consumption by End-Users from 2016 to 2027
-
Table Northwest China Subcutaneous Immunotherapy Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Subcutaneous Immunotherapy Consumption Share by End-Users in 2016
-
Figure Northwest China Subcutaneous Immunotherapy Consumption Share by End-Users in 2021
-
Figure Northwest China Subcutaneous Immunotherapy Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Circassia
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Circassia
-
Figure Sales and Growth Rate Analysis of Circassia
-
Figure Revenue and Market Share Analysis of Circassia
-
Table Product and Service Introduction of Circassia
-
Table Company Profile and Development Status of Allergy Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allergy Therapeutics
-
Figure Sales and Growth Rate Analysis of Allergy Therapeutics
-
Figure Revenue and Market Share Analysis of Allergy Therapeutics
-
Table Product and Service Introduction of Allergy Therapeutics
-
Table Company Profile and Development Status of Aimmune Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Aimmune Therapeutics
-
Figure Sales and Growth Rate Analysis of Aimmune Therapeutics
-
Figure Revenue and Market Share Analysis of Aimmune Therapeutics
-
Table Product and Service Introduction of Aimmune Therapeutics
-
Table Company Profile and Development Status of Merck KGaA
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck KGaA
-
Figure Sales and Growth Rate Analysis of Merck KGaA
-
Figure Revenue and Market Share Analysis of Merck KGaA
-
Table Product and Service Introduction of Merck KGaA
-
Table Company Profile and Development Status of Anergis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Anergis
-
Figure Sales and Growth Rate Analysis of Anergis
-
Figure Revenue and Market Share Analysis of Anergis
-
Table Product and Service Introduction of Anergis
-
Table Company Profile and Development Status of HAL Allergy BV
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of HAL Allergy BV
-
Figure Sales and Growth Rate Analysis of HAL Allergy BV
-
Figure Revenue and Market Share Analysis of HAL Allergy BV
-
Table Product and Service Introduction of HAL Allergy BV
-
Table Company Profile and Development Status of Biomay AG
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biomay AG
-
Figure Sales and Growth Rate Analysis of Biomay AG
-
Figure Revenue and Market Share Analysis of Biomay AG
-
Table Product and Service Introduction of Biomay AG
-
Table Company Profile and Development Status of Stallergenes Greer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Stallergenes Greer
-
Figure Sales and Growth Rate Analysis of Stallergenes Greer
-
Figure Revenue and Market Share Analysis of Stallergenes Greer
-
Table Product and Service Introduction of Stallergenes Greer
-
Table Company Profile and Development Status of DBV Technologies
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of DBV Technologies
-
Figure Sales and Growth Rate Analysis of DBV Technologies
-
Figure Revenue and Market Share Analysis of DBV Technologies
-
Table Product and Service Introduction of DBV Technologies
-
Table Company Profile and Development Status of ALK
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of ALK
-
Figure Sales and Growth Rate Analysis of ALK
-
Figure Revenue and Market Share Analysis of ALK
-
Table Product and Service Introduction of ALK
-
